Tag: FDA enforcement

CHC_general1

OPDP Issues Just Two Enforcement Letters in First Half of 2016

OPDP Enforcement Letter Cites Hospira for Omission of Risk in YouTube Video

Pacira Prevails in Exparel Settlement with FDA

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

What Does OPDP’s Enforcement Lull Mean?

OPDP Enforcement Letters Address Omission of Risk Information

OPDP Issues First Untitled Letter for Branded Facebook Page

OPDP Enforcement Letters Target Common Issues in Last Half of 2013

Caronia Decision One Year Later: Off-label Change May Be Slow, But It’s Brewing